Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis

被引：0
|
作者：
Kato, Motoyasu [1 ]
Nakamura, Takahiro [1 ]
Kono, Kana [1 ]
Haraguchi, Mizuki [1 ]
Yamada, Tomoko [1 ]
Ihara, Hiroaki [1 ]
Takahashi, Fumiyuki [1 ]
Takahashi, Kazuhisa [1 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA4785
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4785
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TREATMENT COST COMPARISON OF PIRFENIDONE VERSUS NINTEDANIB ON THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    Ho, R.
    Rufino, C.
    Lisondo, C.
    Alves, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A893 - A893
  • [42] Real World Experience of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
    Mulholland, S. A.
    Al Jbour, K.
    Steer, H.
    Gutsche, M.
    Foley, N.
    Srivastava, R.
    Sharp, C.
    Adamali, H. I.
    Barratt, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [43] Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
    Bonella, Francesco
    Stowasser, Susanne
    Wollin, Lutz
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 6407 - 6419
  • [44] Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain
    Valenzuela, Claudia
    Molina, Maria Molina
    Portal, Jose Antonio Rodriguez
    Ortiz, Romero
    Cano, Esteban
    Nieto, Maria Jesus Rodriguez
    Laporta, Rosalia
    Ancochea, Julio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [45] LONG-TERM NINTEDANIB TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Song, Jin Woo
    Quaresma, Manuel
    Kaye, Mitchell
    Stansen, Wibke
    Stowasser, Susanne
    Kreuter, Michael
    [J]. RESPIROLOGY, 2017, 22 : 46 - 46
  • [46] Remarkable Improvement in a Patient with Idiopathic Pulmonary Fibrosis after Treatment with Nintedanib
    Nakano, Akiko
    Ohkubo, Hirotsugu
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Oguri, Tetsuya
    Niimi, Akio
    [J]. INTERNAL MEDICINE, 2019, 58 (08) : 1141 - 1144
  • [47] Renal thrombotic microangiopathy during nintedanib treatment for idiopathic pulmonary fibrosis
    Inoue, Daisuke
    Nishi, Hiroshi
    Honda, Kenjiro
    Ishii, Taisuke
    Abe, Hiroyuki
    Sato, Masaaki
    Nangaku, Masaomi
    [J]. CLINICAL NEPHROLOGY, 2020, 93 (01) : 47 - 50
  • [48] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    du Bois, Roland M.
    Raghu, Ganesh
    Azuma, Arata
    Brown, Kevin K.
    Costabel, Ulrich
    Cottin, Vincent
    Flaherty, Kevin R.
    Hansell, David M.
    Inoue, Yoshikazu
    Kim, Dong Soon
    Kolb, Martin
    Nicholson, Andrew G.
    Noble, Paul W.
    Selman, Moises
    Taniguchi, Hiroyuki
    Brun, Michele
    Le Maulf, Florence
    Girard, Mannaig
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Disse, Bernd
    Collard, Harold R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22): : 2071 - 2082
  • [49] Nintedanib slows progression in idiopathic pulmonary fibrosis
    Weiss, Johannes
    [J]. PNEUMOLOGIE, 2018, 72 (02): : 101 - 101
  • [50] Nintedanib for idiopathic pulmonary fibrosis: An Asian perspective
    Chambers, Daniel C.
    [J]. RESPIROLOGY, 2016, 21 (08) : 1342 - 1343
12345